Quick Answer
Roivant Sciences Ltd. reported Diluted EPS of $0.24 per share (loss) for fiscal year 2025.
Roivant Sciences Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.24 | -104.6% |
| 2024 | $5.23 | +468.3% |
| 2023 | -$1.42 | -12.7% |
| 2022 | -$1.26 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.38 | -265.2% | -123.5% |
| September 30, 2025 | -$0.17 | +45.2% | +48.5% |
| June 30, 2025 | -$0.33 | -375.0% | -243.5% |
| December 31, 2024 | $0.23 | -96.2% | +174.2% |
| September 30, 2024 | -$0.31 | +22.5% | -358.3% |
| June 30, 2024 | $0.12 | +131.6% | -98.0% |
| December 31, 2023 | $6.03 | +1330.6% | +1607.5% |
| September 30, 2023 | -$0.40 | +4.8% | -5.3% |
- Roivant Sciences Ltd. showed a decrease of -104.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Roivant Sciences Ltd.’s diluted eps has grown by 81.0% (from $1.26 per share (loss) to $0.24 per share (loss)).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: